A two-faced selectivity solution to target SMARCA2 for cancer therapy.

ABSTRACT:

SUBMITTER: Harling JD 

PROVIDER: S-EPMC9889305 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature